Cargando…
HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
SIMPLE SUMMARY: The inhibitors of histone deacetylases (HDACs) enzymes are an emerging class of drugs proposed for the treatment of several tumors. Despite a general antineoplastic effectiveness, HDACs inhibitors showed conflicting results concerning their effects on the nervous system. Such a discr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654569/ https://www.ncbi.nlm.nih.gov/pubmed/36358670 http://dx.doi.org/10.3390/cancers14215251 |